Artículo

A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022

Resumen

Background N6-methyladenosine (m6A) methylation has become an active research area in viral infection, while little bibliometric analysis has been performed. In this study, we aim to visualize hotspots and trends using bibliometric analysis to provide a comprehensive and objective overview of the current research dynamics in this field. Methods The data related to m6A methylation in viral infection were obtained through the Web of Science Core Collection form 2000 to 2022. To reduce bias, the literature search was conducted on December 1, 2022. Bibliometric and visual analyzes were performed using CiteSpace and Bibliometrix package. After screening, 319 qualified records were retrieved. Results These publications mainly came from 28 countries led by China and the United States (the US), with the US ranking highest in terms of total link strength.The most common keywords were m6A, COVID-19, epitranscriptomics, METTL3, hepatitis B virus, innate immunity and human immunodeficiency virus 1. The thematic map showed that METTL3, plant viruses, cancer progression and type I interferon (IFN-I) reflected a good development trend and might become a research hotspot in the future, while post-transcriptional modification, as an emerging or declining theme, might not develop well. Conclusions In conclusion, m6A methylation in viral infection is an increasingly important topic in articles. METTL3, plant viruses, cancer progression and IFN-I may still be research hotspots and trends in the future.
Tao, Xing (57799888900); Wang, Gang (57210467183); Wei, Wudi (57189600560); Su, Jinming (55808712700); Chen, Xiu (57216164185); Shi, Minjuan (57665868200); Liao, Yinlu (57709210200); Qin, Tongxue (57709127200); Wu, Yuting (57709168000); Lu, Beibei (57709290500); Liang, Hao (57220928681); Ye, Li (7202531493); Jiang, Junjun (47161065500)
A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022
2024
10.1186/s12985-024-02294-1
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182722171&doi=10.1186%2fs12985-024-02294-1&partnerID=40&md5=f96b721052ee4f5b23af8da48dc0bfca
Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Guangxi, Nanning, China; China (Guangxi) – ASEAN Joint Laboratory of Emerging Infectious Diseases, Guangxi Medical University, Guangxi, Nanning, China; Biosafety Level -3 Laboratory, Life Sciences Institute, Guangxi Medical University, Guangxi, Nanning, China
All Open Access; Gold Open Access
Scopus
Artículo obtenido de:
Scopus
0 0 votos
Califica el artículo
Subscribirse
Notificación de